Joseph Schwartz

Director, Biotechnology

Joseph Schwartz joined Leerink Swann’s biotechnology team in 2003. Mr. Schwartz recently earned a #2 ranking in the Wall Street Journal’s “Best on the Street” analysts’ survey for 2008. Before joining Leerink Swann, he provided economic and strategic consulting services to biotechnology and pharmaceutical companies with Charles River Associates. Earlier in his career, Mr. Schwartz held equity research positions at SG Cowen, State Street Research, and JP Morgan, where he analyzed the fundamental performance drivers of investments in the health care, retail, consumer, media, and entertainment sectors. Mr. Schwartz received his MBA from Babson College and his BA in economics from Colby College.